Aarti Pharmalabs Ltd (AARTIPHARM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003784, "name": "Aarti Pharma", "stock_name": "Aarti Pharma", "full_name": "Aarti Pharmalabs Ltd", "name_url": "stocks-analysis/aarti-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "691.80", "chg": 33.3, "chgp": "5.06%", "dir": 1, "prev_price": "658.50", "mcapval": "6,011.00 Cr", "mcap": "Small Cap", "scripcode": 543748, "symbol": "AARTIPHARM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE0LRU01027", "curr_date": "Jun 19, 03:30 PM", "curr_time": "18:49 PM", "last_traded_at": "Jun 19, 03:30 PM IST", "bse_nse_vol": "7.08 lacs", "exc_status": "Active", "traded_date": "Jun 19, 2026", "traded_date_str": "2026 06 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-pharma-1003784-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Aarti Pharmalabs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-4065997", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_mojoScore_4065997.png", "date": "2026-06-21 10:10:35", "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4060481", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4060481.png", "date": "2026-06-18 08:05:31", "description": "Aarti Pharmalabs Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a nuanced change in investor sentiment. Despite a modest day gain of 1.59%, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others maintain a bearish undertone." }, { "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Bearish Indicators", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-bearish-indicators-4058265", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4058265.png", "date": "2026-06-17 08:06:37", "description": "Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day decline of 0.14%, the stock’s technical parameters, including MACD, RSI, Bollinger Bands, and moving averages, reveal a complex picture that investors must carefully analyse amid broader market pressures." }, { "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4055223", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4055223.png", "date": "2026-06-16 08:07:38", "description": "Aarti Pharmalabs Ltd has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a slight decline in the stock price to ₹639.80, the evolving signals from MACD, RSI, moving averages, and other momentum indicators suggest cautious investor sentiment amid broader market pressures." }, { "title": "Aarti Pharmalabs Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-strong-sell-4043909", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_mojoScore_4043909.png", "date": "2026-06-10 10:11:04", "description": "Aarti Pharmalabs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 June 2026, providing investors with the most recent and relevant data to assess the company’s outlook." }, { "title": "Aarti Pharmalabs Ltd Faces Intensified Downtrend Amid Technical Weakness", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-faces-intensified-downtrend-amid-technical-weakness-4040278", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4040278.png", "date": "2026-06-09 08:05:27", "description": "Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating technical parameters such as MACD, moving averages, and Bollinger Bands, underscores mounting selling pressure amid a challenging market backdrop for the pharmaceuticals sector." }, { "title": "Aarti Pharmalabs Declines 11.16%: Mixed Results and Market Volatility Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-declines-1116-mixed-results-and-market-volatility-shape-the-week-4022642", "imagepath": "", "date": "2026-05-30 11:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Stock rallies 2.67% to Rs.733.55 on strong volume</p>\n <p><strong>26 May:</strong> Reports mixed quarterly results; opens with 5.1% gap down</p>\n <p><strong>27 May:</strong> Continued selling pressure drives price down 5.66%</p>\n <p><strong>29 May:</strong> Week closes at Rs.634.75, down 3.28% on heavy volume</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.714.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">R..." }, { "title": "Aarti Pharmalabs Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-4022439", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AartiPharmalabs_mojoScore_4022439.png", "date": "2026-05-30 10:10:31", "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 30 May 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Are Aarti Pharmalabs Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-aarti-pharmalabs-ltd-latest-results-good-or-bad-4014969", "imagepath": "", "date": "2026-05-26 19:34:10", "description": "Aarti Pharmalabs Ltd's financial results for Q4 FY26 present a complex picture of growth and challenges. The company reported consolidated net sales of ₹582.64 crores, reflecting a notable sequential growth of 34.79% from the previous quarter, driven by improved capacity utilization and a favorable product mix. However, the year-on-year comparison shows a modest increase of just 3.35% from ₹563.78 crores in Q4 FY25.\n\nOn the profitability front, consolidated net profit reached ₹61.12 crores, which indicates a sequential improvement of 27.44%. Yet, this figure is significantly lower by 30.81% compared to the same quarter last year. The profit after tax (PAT) margin has also contracted to 10.49%, down from 15.67% a year earlier, highlighting a deterioration in the company's ability to convert revenue into profit amidst rising costs.\n\nOperating margins, excluding other income, fell to 19.42%, down from 23.67% i..." } ], "total": 308, "sid": "1003784", "stock_news_url": "https://www.marketsmojo.com/news/aarti-pharmalabs-1003784" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aarti Pharmalabs Ltd has declared <strong>30%</strong> dividend, ex-date: 16 Feb 26", "dt": "2026-02-16", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Stock rallies 2.67% to Rs.733.55 on strong volume

26 May: Reports mixed quarterly results; opens with 5.1% gap down

27 May: Continued selling pressure drives price down 5.66%

29 May: Week closes at Rs.634.75, down 3.28% on heavy volume

Read full news article

Aarti Pharmalabs Ltd is Rated Sell

2026-05-30 10:10:31

Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 30 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Are Aarti Pharmalabs Ltd latest results good or bad?

2026-05-26 19:34:10

Aarti Pharmalabs Ltd's financial results for Q4 FY26 present a complex picture of growth and challenges. The company reported consolidated net sales of ₹582.64 crores, reflecting a notable sequential growth of 34.79% from the previous quarter, driven by improved capacity utilization and a favorable product mix. However, the year-on-year comparison shows a modest increase of just 3.35% from ₹563.78 crores in Q4 FY25. On the profitability front, consolidated net profit reached ₹61.12 crores, which indicates a sequential improvement of 27.44%. Yet, this figure is significantly lower by 30.81% compared to the same quarter last year. The profit after tax (PAT) margin has also contracted to 10.49%, down from 15.67% a year earlier, highlighting a deterioration in the company's ability to convert revenue into profit amidst rising costs. Operating margins, excluding other income, fell to 19.42%, down from 23.67% i...

Read full news article